republic-os/legislation/us/states/or/2025r1/hb-2385.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	Relating to restrictions on 340B covered entities; and prescribing an effective date.	</b> </i>] Prohibits drug manufacturers from interfering directly or indirectly with a pharmacy or drug outlet acquiring 340B drugs, delivering 340B drugs to certain health care providers or dispensing 340B drugs. Prohibits drug manufacturers from requiring utilization review data from a drug outlet or pharmacy as a condition of the acquisition, delivery or dispensation of a 340B drug. <b>Creates a civil penalty imposed by the State Board of Pharmacy for violations of the provisions of the Act.</b> Takes effect on the 91st day following adjournment sine die.	us/states/or	Oregon Legislative Assembly	2025R1	HB 2385	Oregon HB 2385 (2025R1)	bill		enacted	Deb Patterson Rob Nosse	10	25	6	2025-01-13T16:01:32+00:00	2025-06-24T02:25:10+00:00	openstates	ocd-bill/f468e894-42ac-4ccc-b815-093abdb23562	https://olis.oregonlegislature.gov/liz/2025R1/Measures/Overview/HB2385	9f2d209e0208d2f8d51d05b0194c04c461a147d7784d03fabf59f8ec511438ce	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-or

Oregon HB 2385 (2025R1) — Relating to restrictions on 340B covered entities; and prescribing an effective date.

] Prohibits drug manufacturers from interfering directly or indirectly with a pharmacy or drug outlet acquiring 340B drugs, delivering 340B drugs to certain health care providers or dispensing 340B drugs. Prohibits drug manufacturers from requiring utilization review data from a drug outlet or pharmacy as a condition of the acquisition, delivery or dispensation of a 340B drug. Creates a civil penalty imposed by the State Board of Pharmacy for violations of the provisions of the Act. Takes effect on the 91st day following adjournment sine die.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. House Amendments to Introduced (filed) — source
2. Introduced (filed) — source
3. A-Engrossed (committee substitute) — source
4. B-Engrossed (committee substitute) — source
5. HBHHC Amendment -1 (committee substitute) — source
6. Minority Report to B-Engrossed (committee substitute) — source
7. SHC Amendment -A8 (committee substitute) — source
8. Senate Amendments to A-Engrossed (committee substitute) — source
9. Senate Minority Amendments to A-Engrossed (committee substitute) — source
10. Enrolled (enrolled) — source

Votes

• Heard and Reported Out with Amendments — 7–2 (pass) · lower
• Third reading. Carried by Nosse. Passed. — 37–18 (pass) · lower
• Third reading. Carried by Patterson. Passed. — 17–13 (pass) · upper
• Motion to substitute Minority Report for Committee Report failed. — 12–18 (fail) · upper
• Heard and Reported Out with Amendments — 3–2 (pass) · upper
• House concurred in Senate amendments and repassed bill. — 35–20 (pass) · lower

Sponsors

• Deb Patterson — primary (person)
• Rob Nosse — primary (person)
• Cyrus Javadi — cosponsor (person)
• David Gomberg — cosponsor (person)
• Ed Diehl — cosponsor (person)
• Hai Pham — cosponsor (person)
• James Manning Jr. — cosponsor (person)
• Mark Gamba — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2025-01-13T16:01:32+00:00 First reading. Referred to Speaker's desk. introduction, reading-1, referral-committee
• 2025-01-17T20:47:46+00:00 Referred to Behavioral Health and Health Care. referral-committee
• 2025-03-11T22:01:00+00:00 Public Hearing held.
• 2025-04-01T22:02:00+00:00 Work Session held.
• 2025-04-07T22:33:32+00:00 Recommendation: Do pass with amendments and be printed A-Engrossed. committee-passage-favorable
• 2025-04-08T18:18:07+00:00 Second reading. reading-2
• 2025-04-09T18:31:51+00:00 Rules suspended. Carried over to April 14, 2025 Calendar.
• 2025-04-14T18:42:58+00:00 Third reading. Carried by Nosse. Passed. passage, reading-3
• 2025-04-15T18:32:30+00:00 First reading. Referred to President's desk. introduction, reading-1, referral-committee
• 2025-04-15T20:12:35+00:00 Referred to Health Care. referral-committee
• 2025-04-14T18:43:58+00:00 Vote explanation(s) filed by Nelson.
• 2025-05-06T22:01:00+00:00 Public Hearing held.
• 2025-05-08T22:01:00+00:00 Public Hearing held.
• 2025-05-13T22:02:00+00:00 Work Session held.
• 2025-05-23T19:56:03+00:00 Recommendation: Do pass with amendments to the A-Eng bill. (Printed B-Eng.) Hayden, Linthicum not concurring. committee-passage-favorable
• 2025-05-23T19:56:04+00:00 Minority Recommendation: Do pass with different amendments to the A-Eng bill. (Printed B-Eng. Minority) committee-passage-favorable
• 2025-05-27T18:00:44+00:00 Second reading. reading-2
• 2025-05-28T19:12:18+00:00 Motion to substitute Minority Report for Committee Report failed.
• 2025-05-28T19:45:11+00:00 Third reading. Carried by Patterson. Passed. passage, reading-3
• 2025-05-28T19:46:11+00:00 Vote explanation(s) filed by Sollman.
• 2025-06-02T18:25:53+00:00 House concurred in Senate amendments and repassed bill.
• 2025-06-03T17:29:53+00:00 Speaker signed. passage
• 2025-06-03T22:25:52+00:00 President signed. passage
• 2025-06-11T23:16:13+00:00 Governor signed. executive-signature
• 2025-06-24T02:25:10+00:00 Chapter 297, (2025 Laws): effective on the 91st day following adjournment sine die.

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/f468e894-42ac-4ccc-b815-093abdb23562. Confidence: reported (aggregated from official Oregon legislature records).